Heart injury biomarker may help COVID-19 patients avoid hospitalization, new study shows
A study led by the University of St Andrews suggests that a frequently used medical test for heart injury could one day be used to help COVID-19 patients avoid hospitalisation.
Cardiac troponins are proteins that form part of the heart’s contractile machinery and are released into the bloodstream when the heart is damaged. It can be measured in a blood test which is widely used in the assessment of heart attacks and other heart conditions.
Existing studies since 2020 have shown that COVID-19 patients who have elevated troponin levels are more likely to die or suffer adverse clinical outcomes compared with those who have normal ...









